Epilepsy, the Central Nervous System and Rare Disease episode artwork

EPISODE · Apr 13, 2022 · 21 MIN

Epilepsy, the Central Nervous System and Rare Disease

from The Syneos Health Podcast · host Jeffrey Stewart, Dr. Nermina Nakas and Dr. Jane Williams

Nobody thinks about epilepsy as a rare disease. But epilepsy syndromes actually make up a large portion of CNS rare diseases. And while progress has been made in developing therapies that treat the symptoms of epilepsy, the true underlying causes can be difficult to pinpoint and treat. But progress is being made, and Nermina Nakas, MD, MPH and Jane Williams, MD, MPH, Executive Medical Directors in CNS at Syneos Health – and contributors to the book Rare Disease Drug Development: Clinical, Scientific, Patient and Caregiver Perspectives – join Jeff Stewart to discuss recent developments in rare disease epilepsy clinical trials, what they have learned and what drug developers need to know about treating young patients with neurological rare diseases.For more on the topics covered in this episode, be sure to check out:Innovation Perspectives in Rare Disease Drug DevelopmentThe Syneos Health Podcast: Navigating the Rare Disease LandscapeThe Syneos Health Podcast: Mental Health in Rare DiseaseRare Disease Drug Development: Clinical, Scientific, Patient, and Caregiver PerspectivesIf you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.Like what you’re hearing?  Be sure to rate and review us!  We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at [email protected] views expressed in this podcast belong solely to the speakers and do not represent those of their organization.  If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you’re hearing? Be sure to rate and review us!  We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected]

Episode metadata supplied by the publisher feed · Published Apr 13, 2022

Embed this episode

Nobody thinks about epilepsy as a rare disease. But epilepsy syndromes actually make up a large portion of CNS rare diseases. And while progress has been made in developing therapies that treat the symptoms of epilepsy, the true underlying causes can be difficult to pinpoint and treat. But progress is being made, and Nermina Nakas, MD, MPH and Jane Williams, MD, MPH, Executive Medical Directors in CNS at Syneos Health – and contributors to the book Rare Disease Drug Development: Clinica...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Epilepsy, the Central Nervous System and Rare Disease

0:00 21:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Syneos Health Podcast?

This episode is 21 minutes long.

When was this The Syneos Health Podcast episode published?

This episode was published on April 13, 2022.

Can I download this The Syneos Health Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!